BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26324747)

  • 21. Cardiovascular Mortality Following Short-term Androgen Deprivation in Clinically Localized Prostate Cancer: An Analysis of RTOG 94-08.
    Voog JC; Paulus R; Shipley WU; Smith MR; McGowan DG; Jones CU; Bahary JP; Zeitzer KL; Souhami L; Leibenhaut MH; Rotman M; Husain SM; Gore E; Raben A; Chafe S; Sandler HM; Efstathiou JA
    Eur Urol; 2016 Feb; 69(2):204-10. PubMed ID: 26362090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence and trends of cardiovascular mortality after common cancers in young adults: Analysis of surveillance, epidemiology and end-results program.
    Al-Kindi SG; Oliveira GH
    World J Cardiol; 2016 Jun; 8(6):368-74. PubMed ID: 27354894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study.
    Lai Y; Wang C; Civan JM; Palazzo JP; Ye Z; Hyslop T; Lin J; Myers RE; Li B; Jiang B; Sama A; Xing J; Yang H
    Gastroenterology; 2016 May; 150(5):1135-1146. PubMed ID: 26836586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group.
    Albain KS; Unger JM; Crowley JJ; Coltman CA; Hershman DL
    J Natl Cancer Inst; 2009 Jul; 101(14):984-92. PubMed ID: 19584328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
    Ali S; Olszewski AJ
    Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular-Specific Mortality among Gastrointestinal Stromal Tumor Patients: A Population-Based Analysis.
    Yao H; Shi H; Fan M; Yuan L; Lin R
    Oxid Med Cell Longev; 2023; 2023():3619306. PubMed ID: 36825080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
    van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
    JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer.
    Rigter LS; Schaapveld M; Janus CPM; Krol ADG; van der Maazen RWM; Roesink J; Zijlstra JM; van Imhoff GW; Poortmans PMP; Beijert M; Lugtenburg PJ; Visser O; Snaebjornsson P; van Eggermond AM; Aleman BMP; van Leeuwen FE; van Leerdam ME
    Cancer Med; 2019 Jan; 8(1):190-199. PubMed ID: 30592184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced Mortality Risk in the Recent Era in Early-Stage Hodgkin Lymphoma Patients Treated With Radiation Therapy With or Without Chemotherapy.
    Patel CG; Michaelson E; Chen YH; Silver B; Marcus KJ; Stevenson MA; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):498-506. PubMed ID: 29153331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood.
    Matasar MJ; Ford JS; Riedel ER; Salz T; Oeffinger KC; Straus DJ
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25717170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
    Krul IM; Boekel NB; Kramer I; Janus CPM; Krol ADG; Nijziel MR; Zijlstra JM; van der Maazen RWM; Roesink JM; Jacobse JN; Schaapveld M; Schmidt MK; Opstal-van Winden AWJ; Sonke GS; Russell NS; Aleman BMP; van Leeuwen FE
    Cancer; 2022 Dec; 128(24):4285-4295. PubMed ID: 36281718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved survival time trends in Hodgkin's lymphoma.
    Koshy M; Fairchild A; Son CH; Mahmood U
    Cancer Med; 2016 Jun; 5(6):997-1003. PubMed ID: 26999817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pediatric hodgkin lymphoma: disparities in survival by race.
    Khullar K; Rivera-Núñez Z; Jhawar SR; Drachtman R; Cole PD; Hoppe BS; Parikh RR
    Leuk Lymphoma; 2020 Mar; 61(3):546-556. PubMed ID: 31640446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
    Xavier AC; Armeson KE; Hill EG; Costa LJ
    Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased risk of cerebrovascular mortality in head and neck cancer survivors aged ≥ 65 years treated with definitive radiotherapy: a population-based cohort study.
    He QS; Wang ZP; Li ZJ; Zhou P; Lian CL; Wu SG; Chen SF
    Radiat Oncol; 2021 Sep; 16(1):185. PubMed ID: 34544466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relapsed hodgkin lymphoma in older patients: a comprehensive analysis from the German hodgkin study group.
    Böll B; Goergen H; Arndt N; Meissner J; Krause SW; Schnell R; von Tresckow B; Eichenauer DA; Sasse S; Fuchs M; Behringer K; Klimm BC; Naumann R; Diehl V; Engert A; Borchmann P
    J Clin Oncol; 2013 Dec; 31(35):4431-7. PubMed ID: 24190119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
    J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disparities in survival after Hodgkin lymphoma: a population-based study.
    Keegan TH; Clarke CA; Chang ET; Shema SJ; Glaser SL
    Cancer Causes Control; 2009 Dec; 20(10):1881-92. PubMed ID: 19557531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late Relapse of Classical Hodgkin Lymphoma: An Analysis of the German Hodgkin Study Group HD7 to HD12 Trials.
    Bröckelmann PJ; Goergen H; Kohnhorst C; von Tresckow B; Moccia A; Markova J; Meissner J; Kerkhoff A; Ludwig WD; Fuchs M; Borchmann P; Engert A
    J Clin Oncol; 2017 May; 35(13):1444-1450. PubMed ID: 28240973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma.
    Jhawar SR; Rivera-Núñez Z; Drachtman R; Cole PD; Hoppe BS; Parikh RR
    JAMA Oncol; 2019 May; 5(5):689-695. PubMed ID: 30605220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.